AVITA Medical (FRA:51KA) EPS (Diluted) : €-1.30 (TTM As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is AVITA Medical EPS (Diluted)?

AVITA Medical's Earnings per Share (Diluted) for the three months ended in Dec. 2023 was €-0.26. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was €-1.30.

AVITA Medical's EPS (Basic) for the three months ended in Dec. 2023 was €-0.26. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2023 was €-1.30.

AVITA Medical's EPS without NRI for the three months ended in Dec. 2023 was €-0.26. Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2023 was €-1.30.

During the past 3 years, the average EPS without NRIGrowth Rate was 12.20% per year. During the past 5 years, the average EPS without NRI Growth Rate was 4.50% per year. During the past 10 years, the average EPS without NRI Growth Rate was 1.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, AVITA Medical's highest 3-Year average EPS without NRI Growth Rate was 72.40% per year. The lowest was -78.80% per year. And the median was 12.00% per year.

AVITA Medical EPS (Diluted) Historical Data

The historical data trend for AVITA Medical's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AVITA Medical EPS (Diluted) Chart

AVITA Medical Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Dec22

Dec23

EPS (Diluted)

Get a 7-Day Free Trial

-1.38

-1.84

-0.97

-1.01

-1.28

AVITA Medical Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EPS (Diluted)	Get a 7-Day Free Trial															-0.21	-0.35	-0.38	-0.32	-0.26

Competitive Comparison of AVITA Medical's EPS (Diluted)

For the Medical Devices subindustry, AVITA Medical's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

AVITA Medical's PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, AVITA Medical's PE Ratio distribution charts can be found below:

* The bar in red indicates where AVITA Medical's PE Ratio falls into.

AVITA Medical EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

AVITA Medical's Diluted EPS for the fiscal year that ended in Dec. 2023 is calculated as

Diluted EPS (A: Dec. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Diluted Average)
	=	(-32.444	-	0)	/	25.331
	=	-1.28

AVITA Medical's Diluted EPS for the quarter that ended in Dec. 2023 is calculated as

Diluted EPS (Q: Dec. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Diluted Average)
	=	(-6.479	-	0)	/	25.479
	=	-0.25

EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €-1.30

AVITA Medical (FRA:51KA) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

AVITA Medical EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of AVITA Medical's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.

AVITA Medical (FRA:51KA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » AVITA Medical Inc (FRA:51KA) » Definitions » EPS (Diluted)

Comparable Companies

Traded in Other Exchanges

RCEL:USA AVHHL:USA 51KB:Germany AVH:Australia

Address

28159 Avenue Stanford, Suite 220, Valencia, Los Angeles, CA, USA, 91355

Website

https://www.avitamedical.com

Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult patients in the U.S. with paediatric clinical trials and expanded indications in soft-tissue reconstruction and vitiligo underway. It is currently in roll-out across the approximately 136 U.S. burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the U.S. region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the U.S.

AVITA Medical (FRA:51KA) Headlines

No Headlines